Loading
Total declarations
Companies
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Oct 2015 for INSITE VISION INC, €82k.
Insider track record
Disclosed buys
13
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
13
Positive at T+90
17%
Median T+90
-12.0%
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -77.1%Entry US$911.40 · Close at T+365 US$208.60
- -40.6%Entry US$172.35 · Close at T+365 US$102.45
- -62.9%Entry US$225.45 · Close at T+365 US$83.55
- -45.9%Entry US$240.90 · Close at T+365 US$130.35
- -42.2%Entry US$297.45 · Close at T+365 US$171.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Louis Drapeau: trading record in brief
Louis Drapeau has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Nektar Therapeutics, Insite Vision Inc and Intermune Inc. The record holds 20 filings, for trades running from 3 March 2006 to 28 October 2015.
On the market, this insider has only ever bought: 13 purchases, €234k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 1 option exercise. 2015 to date brings 1 purchase and no sales.
The median purchase comes to €11k. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 17% of cases; the median change was -12.0%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 30 October 2015 with a transaction (€82k) in Insite Vision Inc. The latest purchase dates back some time: it was published 4,034 days ago, on 7 October 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Louis Drapeau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
260,000 shares@ US$0.35Common StockSEC:0001209191-15-077357:0
10,000 shares@ US$4.39Common StockSEC:0001209191-15-074515:0
Canonical exit: 4 Jan 2016 (T+90)
7,500 shares@ US$74.00Common stockSEC:0001209191-14-060745:0
3,000 shares0Common stockSEC:0001209191-14-038491:0
2,500 shares@ US$10.10Common StockSEC:0001209191-12-032677:0
200,000 shares@ US$0.60Common StockSEC:0001181431-11-041741:0
Canonical exit: 16 Oct 2011 (T+90)
20,000 shares@ US$0.89Common StockSEC:0001181431-11-033425:0
10,000 shares@ US$0.97Common StockSEC:0001181431-10-051587:0
Canonical exit: 17 Jan 2011 (T+90)
13,000 shares@ US$0.35Common StockSEC:0001140361-08-026942:0
Canonical exit: 26 Feb 2009 (T+90)
17,000 shares@ US$0.38Common StockSEC:0001140361-08-026942:1
Canonical exit: 1 Mar 2009 (T+90)
1,000 shares@ US$17.45Common StockSEC:0001209191-08-046025:0
Canonical exit: 4 Nov 2008 (T+90)
10,000 shares@ US$0.78Common StockSEC:0001181431-08-015131:0
Canonical exit: 29 May 2008 (T+90)
30,000 shares@ US$1.17Common StockSEC:0001181431-07-068417:0
1,000 shares@ US$16.81Common StockSEC:0001209191-07-063081:0
Canonical exit: 6 Feb 2008 (T+90)
1,000 shares@ US$12.15Common StockSEC:0001179110-07-009955:0
1,000 shares@ US$11.77Common StockSEC:0001179110-07-005307:0
Canonical exit: 3 Jun 2007 (T+90)
1,000 shares@ US$14.65Common StockSEC:0001179110-06-021088:0
Canonical exit: 5 Feb 2007 (T+90)
1,000 shares@ US$16.35Common StockSEC:0001104659-06-053691:0
Canonical exit: 6 Nov 2006 (T+90)
1,000 shares@ US$20.35Common StockSEC:0001179110-06-010853:0
Canonical exit: 13 Aug 2006 (T+90)
1,000 shares@ US$20.08Common StockSEC:0001179110-06-005524:0
Canonical exit: 1 Jun 2006 (T+90)
20 of 20 declarations
